Investigating the role of specific brain cells in a condition linked to Alzheimer's disease
Perivascular fibroblasts, vascular fibrosis, and their contributions to cerebral amyloid angiopathy
This study is looking at how certain brain cells might play a role in a condition called cerebral amyloid angiopathy (CAA), which can happen with Alzheimer's disease and lead to problems like dementia and bleeding in the brain, to help find new ways to treat it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10577536 on NIH RePORTER |
What this research studies
This research focuses on cerebral amyloid angiopathy (CAA), a condition where amyloid beta deposits form on blood vessels in the brain, often occurring alongside Alzheimer's disease. The study aims to understand how certain brain cells, known as perivascular fibroblasts, contribute to the development of CAA and its associated risks, such as dementia and intracranial hemorrhage. By examining postmortem brain tissue from CAA patients and using animal models, researchers will explore the signaling pathways involved in this condition. The goal is to uncover the molecular mechanisms behind CAA to pave the way for potential new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cerebral amyloid angiopathy, particularly those who may also have Alzheimer's disease.
Not a fit: Patients without any form of dementia or those who do not have cerebral amyloid angiopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating cerebral amyloid angiopathy and potentially improve outcomes for patients with Alzheimer's disease.
How similar studies have performed: While the specific approach of targeting perivascular fibroblasts in CAA is novel, previous research has shown that understanding the cellular mechanisms in similar conditions can lead to breakthroughs in treatment.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Lippmann, Ethan — Vanderbilt University
- Study coordinator: Lippmann, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.